Your browser is no longer supported. Please, upgrade your browser.
Settings
A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E51.16 EPS (ttm)2.60 Insider Own0.40% Shs Outstand306.00M Perf Week1.98%
Market Cap40.23B Forward P/E30.55 EPS next Y4.36 Insider Trans-18.54% Shs Float304.48M Perf Month8.36%
Income810.00M PEG4.74 EPS next Q0.82 Inst Own90.90% Short Float0.88% Perf Quarter4.96%
Sales5.53B P/S7.28 EPS this Y-31.60% Inst Trans0.33% Short Ratio1.61 Perf Half Y26.43%
Book/sh15.70 P/B8.49 EPS next Y11.84% ROA8.50% Target Price139.00 Perf Year72.98%
Cash/sh4.40 P/C30.27 EPS next 5Y10.80% ROE16.70% 52W Range73.42 - 136.98 Perf YTD12.48%
Dividend0.78 P/FCF46.41 EPS past 5Y12.00% ROI10.00% 52W High-2.20% Beta1.01
Dividend %0.59% Quick Ratio1.60 Sales past 5Y5.70% Gross Margin53.30% 52W Low82.47% ATR2.35
Employees16400 Current Ratio2.10 Sales Q/Q14.10% Oper. Margin17.30% RSI (14)68.15 Volatility1.30% 1.59%
OptionableYes Debt/Eq0.52 EPS Q/Q48.10% Profit Margin14.60% Rel Volume0.78 Prev Close133.28
ShortableYes LT Debt/Eq0.45 EarningsFeb 16 AMC Payout27.40% Avg Volume1.66M Price133.97
Recom2.00 SMA205.21% SMA507.38% SMA20020.68% Volume683,518 Change0.52%
Mar-18-21Upgrade Citigroup Neutral → Buy $135 → $150
Feb-17-21Upgrade BofA Securities Neutral → Buy $147
Dec-02-20Initiated Goldman Buy $130
Nov-25-20Upgrade UBS Neutral → Buy $103 → $132
Nov-17-20Upgrade Cleveland Research Neutral → Buy
Nov-10-20Initiated KeyBanc Capital Markets Overweight $130
Sep-30-20Initiated Atlantic Equities Neutral $105
Aug-19-20Reiterated Wells Fargo Overweight $100 → $105
Aug-19-20Reiterated SVB Leerink Outperform $95 → $100
Aug-19-20Reiterated Stifel Hold $85 → $100
Aug-19-20Reiterated Robert W. Baird Outperform $87 → $104
Aug-19-20Reiterated Jefferies Buy $95 → $110
Aug-19-20Reiterated Citigroup Neutral $85 → $100
Aug-19-20Reiterated BofA Securities Neutral $99 → $103
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Apr-15-21 04:05PM  
Apr-14-21 04:25PM  
10:00AM  
09:58AM  
Apr-13-21 08:00PM  
Apr-10-21 03:01AM  
Apr-08-21 12:28PM  
12:00PM  
Apr-05-21 01:32PM  
Apr-01-21 12:47PM  
Mar-30-21 08:00AM  
Mar-25-21 11:25AM  
Mar-24-21 11:59AM  
Mar-22-21 09:51AM  
Mar-18-21 11:30AM  
09:09AM  
Mar-17-21 04:05PM  
Mar-16-21 08:49AM  
Mar-15-21 08:00AM  
Mar-11-21 12:57PM  
10:04AM  
Mar-10-21 11:04PM  
Mar-09-21 12:07PM  
08:00AM  
Mar-03-21 05:56PM  
11:05AM  
10:03AM  
08:40AM  
Mar-02-21 08:00AM  
02:00AM  
Feb-22-21 01:46PM  
Feb-19-21 02:15PM  
Feb-18-21 11:11PM  
05:36PM  
08:00AM  
Feb-17-21 10:10AM  
08:00AM  
Feb-16-21 11:30PM  
04:20PM  
04:10PM  
04:05PM  
Feb-12-21 09:28AM  
07:47AM  
Feb-10-21 11:11AM  
Feb-09-21 12:30PM  
12:00PM  
Feb-08-21 02:00PM  
Feb-03-21 05:30AM  
Feb-02-21 12:10PM  
Feb-01-21 11:00AM  
Jan-26-21 11:00AM  
Jan-25-21 08:00AM  
Jan-24-21 11:12PM  
Jan-15-21 01:37PM  
Dec-23-20 11:30AM  
Dec-22-20 10:00PM  
Dec-21-20 10:16AM  
Dec-20-20 01:37AM  
Dec-16-20 11:00AM  
Dec-14-20 08:00AM  
Dec-11-20 10:00AM  
Dec-07-20 12:30AM  
Dec-06-20 03:00PM  
Dec-03-20 08:00AM  
Dec-02-20 08:00AM  
Nov-30-20 08:00AM  
Nov-24-20 05:48AM  
Nov-23-20 09:30PM  
05:42PM  
05:30PM  
04:29PM  
04:05PM  
10:51AM  
08:00AM  
Nov-22-20 03:00PM  
Nov-20-20 08:56AM  
Nov-19-20 10:00AM  
Nov-18-20 04:05PM  
08:48AM  
Nov-17-20 08:32AM  
07:07AM  
Nov-16-20 12:30PM  
Nov-13-20 08:26PM  
Nov-04-20 09:55AM  
08:00AM  
Nov-02-20 12:10PM  
Oct-29-20 11:21PM  
03:00PM  
Oct-26-20 06:15PM  
Oct-23-20 06:17AM  
Oct-19-20 07:38AM  
Oct-15-20 08:00AM  
Oct-14-20 08:00AM  
Oct-08-20 10:32AM  
Oct-07-20 04:44PM  
Sep-30-20 09:41AM  
Sep-17-20 11:30AM  
08:00AM  
06:42AM  
Sep-16-20 04:05PM  
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McMullen Michael R.CEO and PresidentApr 13Sale132.508,9661,187,995270,158Apr 15 06:47 PM
McMullen Michael R.CEO and PresidentApr 08Sale130.2615,0951,966,275279,124Apr 12 07:01 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 22Sale124.175,000620,85041,229Feb 24 05:54 PM
Grau DominiqueSenior Vice PresidentFeb 17Option Exercise40.809,034368,58795,071Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 17Sale133.0050066,50053,530Feb 18 06:48 PM
Grau DominiqueSenior Vice PresidentFeb 17Sale135.1113,7451,857,08781,326Feb 18 06:31 PM
Grau DominiqueSenior Vice PresidentFeb 16Sale130.146,041786,19486,037Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 16Sale129.3150064,65554,030Feb 18 06:48 PM
McMullen Michael R.CEO and PresidentFeb 16Sale130.0020,7662,699,580294,219Feb 18 06:33 PM
McMullen Michael R.CEO and PresidentFeb 02Sale123.7441,9785,194,232314,985Feb 03 01:28 PM
McMullen Michael R.CEO and PresidentFeb 01Sale120.2621,2122,550,955356,963Feb 03 01:28 PM
Tang MichaelSVP, General Counsel, and Sec.Jan 14Sale127.2750063,63554,880Jan 19 05:01 PM
McMullen Michael R.CEO and PresidentDec 01Sale115.6385,8429,925,910415,347Dec 02 08:17 PM
KOH BOON HWEEDirectorNov 30Sale114.5120,0002,290,20068,051Dec 02 08:16 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 09Sale116.162,222258,10856,807Nov 12 01:31 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 05Sale111.001,111123,32159,029Nov 09 02:33 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 04Sale108.501,111120,54460,140Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 03Sale106.431,111118,24461,251Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 02Sale103.521,111115,01162,362Nov 03 03:41 PM
Tang MichaelSVP, General Counsel, and Sec.Oct 30Sale101.773,333339,19963,473Nov 03 03:41 PM
Grau DominiqueSenior Vice PresidentOct 09Option Exercise39.126,485253,693104,154Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentOct 09Sale105.006,485680,92597,669Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentAug 31Option Exercise39.126,485253,693104,154Sep 01 05:19 PM
Grau DominiqueSenior Vice PresidentAug 31Sale100.006,485648,50097,669Sep 01 05:19 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Option Exercise40.806,191252,59348,334Aug 27 12:15 PM
Gonsalves RodneyV.P., Corporate ControllerAug 25Sale98.176,191607,75242,143Aug 27 12:15 PM
McMullen Michael R.CEO and PresidentJul 30Option Exercise39.1272,7162,844,650575,215Aug 03 02:42 PM
McMullen Michael R.CEO and PresidentJul 30Sale95.7672,7166,963,575502,499Aug 03 02:42 PM
FIELDS HEIDIDirectorJun 04Sale91.0010,392945,6620Jun 08 02:08 PM
Gonsalves RodneyV.P., Corporate ControllerMay 27Option Exercise40.803,100126,48046,709May 28 07:04 PM
Gonsalves RodneyV.P., Corporate ControllerMay 27Sale85.304,566389,49942,143May 28 07:04 PM
Grau DominiqueSenior Vice PresidentMay 26Option Exercise26.199,033236,574106,702May 28 07:02 PM
Thaysen JacobSr. Vice PresidentMay 26Sale86.538,000692,240102,806May 28 07:03 PM
Grau DominiqueSenior Vice PresidentMay 26Sale86.569,033781,89697,669May 28 07:02 PM
McMullen Michael R.CEO and PresidentMay 15Sale82.506,917570,652504,642May 19 03:36 PM
McMullen Michael R.CEO and PresidentMay 08Sale80.0018,0181,441,440511,559May 11 01:42 PM
McMullen Michael R.CEO and PresidentApr 29Sale78.7213,6031,070,774529,245Apr 30 02:55 PM
McMullen Michael R.CEO and PresidentApr 27Sale76.198,814671,583542,848Apr 28 04:58 PM